RXPC Insider Trading Activity and SEC Form 4 Filings
RXPC insider trading summary
No open-market insider purchases or sales of RADIENT PHARMACEUTICALS Corp (RXPC) have been reported on SEC Form 4 in the past 12 months.
Latest RXPC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 28, 2011 | Alpha Capital Anstalt | Insider | Sell | $31K (5,052,094 @ $0.01) |
| Oct 27, 2011 | Alpha Capital Anstalt | Insider | Sell | $11K (1,400,000 @ $0.01) |
| Jul 13, 2011 | Whalehaven Capital Fund Ltd | Insider | Sell | $20K (233,000 @ $0.08) |
| Jul 12, 2011 | Whalehaven Capital Fund Ltd | Insider | Sell | $74K (905,000 @ $0.08) |
| Jul 11, 2011 | Whalehaven Capital Fund Ltd | Insider | Sell | $25K (225,000 @ $0.11) |
| Jul 11, 2011 | Alpha Capital Anstalt | Insider | Sell | $143K (1,460,688 @ $0.10) |
| Jul 8, 2011 | Whalehaven Capital Fund Ltd | Insider | Sell | $7K (59,000 @ $0.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.